ESPR
Esperion Therapeutics, Inc.Company with tickers: ESPR
CIK
1434868
CUSIP
29664W105
Shares Outstanding
257,431,942
13F Activity (30d)
176 filings
174 filers
Price
$3.12
Market Cap
$803.19M
P/E Ratio
-28.36
EPS (Diluted)
$-0.11
52W High
$4.18
52W Low
$0.76
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $80,104,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $86,685,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Research & Development | — | ||||
| Operating Income | $-6,581,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Net Income | $-25,196,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Basic) | $-0.10 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Diluted) | $-0.10 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |